The marketing in this space is often overblown particularly in international cosmetic medicine markets where glutathione is positioned as a generalized skin whitening agent
The STEP (Semaglutide Treatment Effect in People with obesity) trials, which evaluated semaglutide for weight management, documented gallbladder disorders in approximately 2.6% of participants receiving the medication versus 1.2% in the placebo group
writing original draft preparation: AP, ES, DS, and AB
Sources: Bodman & Aboud, Baigrie & Tanner, Hematol Oncol Clin North Am , J Am Acad Dermatol , Am J Clin Pathol , AMA Arch Derm Syphilol , Hum Pathol , Arch Dermatol , Dermatol Pract Concept , Arch Dermatol , Clin Dermatol , NCI Visuals Online
Mercury exposure can lead to kidney damage, neurological issues, and adverse effects during pregnancy